Dana-Farber Cancer Institute
The Scientist position at Dana-Farber Cancer Institute involves developing and implementing next-generation sequencing (NGS) workflows to advance knowledge of genome instability in HR-deficient cancers and translate findings into therapeutic applications. The role requires direct interaction with academic and biopharma industry partners to drive research and innovation. The position includes supervising technical assistants and contributing to manuscripts and grant applications.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
1947
Dana‑Farber Cancer Institute, based in Boston, MA, is a world‑leading cancer center specializing in adult and pediatric cancer treatment and research. Its physician‑scientists deliver multidisciplinary patient care and develop many of the most advanced therapies, including targeted treatments and clinical trials. Dana‑Farber combines cutting‑edge laboratory research with translational programs, prevention and survivorship services, and education to improve outcomes. Patients and clinicians turn to Dana‑Farber for its expertise, comprehensive care teams, and strong research pipeline.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dana-Farber Cancer Institute.
36% below the average for this role
DNA company aids Horry Co. in solving cold cases
Nov 26, 2025
Technical Application Scientist
Twist Bioscience
Research Technician II/III
University Health Network
Applications Scientist - NGS
Leica Biosystems
Research Scientist
ICON plc
Postdoctoral Fellow in Diabetes, Obesity and Metabolism Institute, Mount Sinai, NY
mountsinaihospital.com
Genome Specialist
Hamilton Health Sciences